Will pneumococci put quinolones in their place?

被引：22

作者：

Legg, JM ^{[1
]}

Bint, AJ ^{[1
]}

机构：

[1] Royal Victoria Infirm, Clin Microbiol & Publ Hlth Lab, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 1999年 / 44卷 / 04期

关键词：

D O I：

10.1093/jac/44.4.425

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：425 / 427

页数：3

共 19 条

[1]

COOPER B, 1989, AM J MED, V87, P475

[2] INAPPROPRIATE USE OF ORAL CIPROFLOXACIN [J].

FRIEDEN, TR ;

MANGI, RJ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 264 (11) :1438-1440

[3] COMPARATIVE EFFICACIES OF CIPROFLOXACIN, AMOXICILLIN, AMOXICILLIN-CLAVULANIC ACID, AND CEFACLOR AGAINST EXPERIMENTAL STREPTOCOCCUS-PNEUMONIAE RESPIRATORY-INFECTIONS IN MICE [J].

GISBY, J ;

WIGHTMAN, BJ ;

BEALE, AS .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (05) :831-836

[4] SUPERINFECTION WITH STREPTOCOCCUS-PNEUMONIAE DURING THERAPY WITH CIPROFLOXACIN [J].

GORDON, JJ ;

KAUFFMAN, CA .

AMERICAN JOURNAL OF MEDICINE, 1990, 89 (03) :383-384

[5]

Johnson AP, 1996, J ANTIMICROB CHEMOTH, V38, P907

[6]

KAYSER FH, 1987, AM J MED, V82, P33

[7] In vitro susceptibility of penicillin-resistant Streptococcus pneumoniae to levofloxacin, selection of resistant mutants, and time-kill synergy studies of levofloxacin combined with vancomycin, teicoplanin, fusidic acid, and rifampin [J].

Klugman, KP ;

Capper, T ;

Bryskier, A .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (12) :2802-2804

[8]

KORNER RJ, 1994, BRIT MED J, V308, P191

[9] Randomized, double-blind study of grepafloxacin versus amoxycillin in patients with acute bacterial exacerbations of chronic bronchitis [J].

Langan, CE ;

Cranfield, R ;

Breisch, S ;

Pettit, R .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 :63-72

[10]

LEE BL, 1991, NEW ENGL J MED, V325, P520

← 1 2 →